Similarly to colorectal cancer, we observed that ephrinB2 is frequently silenced in GBM by gene inactivation and promoter hypermethylation, is downregulated in invading cells and that ephrinB2 silencing promotes glioma invasion. The gene discussed is EFNB2; the disease is glioblastoma.